Predicción y previsión de precio de Veradermics Inc (MANE)MANEVeradermics Inc

Alphio's MANE stock price prediction model matches the current Veradermics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $141.18 (+1.73%). The 1-week path is $138.18 (-0.43%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

VeraDermics, Inc. (MANE) is a good buy right now due to its recent positive clinical trial results for its hair loss treatment, which saw 88.9% of participants reporting improvement, and an impressive year-to-date change of +716.35%. The stock is currently priced at $138.78, with analysts projecting a price target of $160 from Citi, suggesting a potential upside of 15.4%. However, the company has reported significant net losses, with a net income of -30,011,000 USD in Q1 2026, which remains a key risk.

Veradermics Inc (MANE) last closed at $138.78, gaining +0.21%. These facts feed the 1-day and 1-week MANE price prediction above.